High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba
✍ Scribed by Vivian Kourí; Yoan Alemán; Lissette Pérez; Jorge Pérez; Carlos Fonseca; Consuelo Correa; Carlos Aragonés; Jorge Campos; Delmis Álvarez; Yoeri Schrooten; Nathalie Dekeersmaeker; Stijn Imbrechts; Gertjan Beheydt; Lore Vinken; Daniel Pérez; Alina Álvarez; Yudira Soto; Anne-Mieke Vandamme; Kristel Van Laethem
- Book ID
- 119292737
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 639 KB
- Volume
- 55
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Phylogenetic analysis and evaluation of drug‐resistance were carried out upon 59 plasma samples from 58 treatment‐naïve HIV‐1 infected patients from Mozambique, enrolled in a free antiviral‐therapy protocol in the frame of Drug‐Resource‐Enhancement against AIDS and Malnutrition (DREAM)
## Abstract Etravirine (ETR) is a non‐nucleoside analogue reverse transcriptase inhibitor (NNRTI) with a high genetic barrier to the development of resistance and with potential activity against __Human immunodeficiency virus type 1__ (HIV‐1) strains resistant to first‐generation NNRTIs. The object